诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09969 诺诚健华

已收盘 03-11 16:08:15

11.820

-0.360

-2.96%

最高12.270	最低11.710	成交量368.20万
今开12.180	昨收12.180	日振幅4.60%
总市值208.27亿	流通市值176.59亿	总股本17.62亿
成交额4,370万	换手率0.25%	流通股本14.94亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09969","market":"HK","secType":"STK","nameCN":"诺诚健华","latestPrice":11.82,"timestamp":1773216495008,"preClose":12.18,"halted":0,"volume":3682000,"delay":0,"changeRate":-0.029556650246305372,"floatShares":1494000000,"shares":1762000000,"eps":-0.27,"marketStatus":"已收盘","change":-0.36,"latestTime":"03-11 16:08:15","open":12.18,"high":12.27,"low":11.71,"amount":43701460,"amplitude":0.045977,"askPrice":11.82,"askSize":38000,"bidPrice":11.8,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.143,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773279000000},"marketStatusCode":5,"adr":0,"listingDate":1584892800000,"exchange":"SEHK","adjPreClose":12.18,"openAndCloseTimeList":[[1773192600000,1773201600000],[1773205200000,1773216000000]],"volumeRatio":0.54139,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"诺诚健华","latestPrice":23.4,"timestamp":1773212400000,"preClose":23.81,"halted":0,"volume":6145900,"delay":0,"premium":"-55.63"}},"requestUrl":"/m/hq/s/09969","defaultTab":"news","newsList":[{"id":"2618928493","title":"诺诚健华：公司预计2025年度首次实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2618928493","media":"证券日报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618928493?lang=zh_cn&edition=full","pubTime":"2026-03-11 21:36","pubTimestamp":1773236199,"startTime":"0","endTime":"0","summary":"证券日报网讯3月11日，诺诚健华在互动平台回答投资者提问时表示，根据公司业绩预告，公司预计2025年度首次实现扭亏为盈，预计2025年实现营业总收入人民币23.65亿元左右，与上年同期相比增长134%左右，归属于母公司所有者的净利润为6.33亿元左右。公司对于未来包括奥布替尼在内的药品销售、管线进展及商业化合作充满信心。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603113669094746.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1574","688428","BK1161","09969","BK0239"],"gpt_icon":0},{"id":"2618619980","title":"3月10日诺诚健华涨6.01%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618619980","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618619980?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:22","pubTimestamp":1773130927,"startTime":"0","endTime":"0","summary":"证券之星消息，3月10日诺诚健华涨6.01%，收盘报23.81元，换手率3.62%，成交量9.71万手，成交额2.29亿元。重仓诺诚健华的前十大公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.77亿元，最新净值2.8444，较上一交易日下跌1.51%，近一年上涨16.38%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000024267.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09969","BK1574","BK0239","688428","BK1161"],"gpt_icon":0},{"id":"2618987734","title":"每日卖空追踪 | 诺诚健华 03月09日卖空量成交15.2万股，卖空比例为2.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618987734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618987734?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045043,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间03月09日，跌0.42%，卖空量成交15.2万股，较上一交易日减少36.93%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163639a45aea90&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163639a45aea90&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1574","BK1161"],"gpt_icon":0},{"id":"2617663338","title":"每周股票复盘：诺诚健华（688428）股本结构稳定无新增发行","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663338","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663338?lang=zh_cn&edition=full","pubTime":"2026-03-08 03:00","pubTimestamp":1772910037,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，诺诚健华报收于22.68元，较上周的23.3元下跌2.66%。本周，诺诚健华3月2日盘中最高价报23.48元。诺诚健华当前最新总市值400.22亿元，在化学制药板块市值排名11/150，在两市A股市值排名521/5190。本周关注点公司公告汇总：诺诚健华截至2026年2月28日股本无变动，已发行股份总数为1,496,284,235股。另有于上交所科创板上市的人民币股份268,359,717股。公司确认公众持股量符合港交所上市规则要求。存在股权激励计划安排，但本月未发生新股发行或库存股转让。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001022.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688428","09969","BK1161","BK1574","BK0239"],"gpt_icon":0},{"id":"2617652082","title":"每日卖空追踪 | 诺诚健华 03月06日卖空量成交17.9万股，卖空比例为2.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617652082","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617652082?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:30","pubTimestamp":1772785842,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间03月06日，涨5.44%，卖空量成交17.9万股，较上一交易日减少69.87%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163623a4535eda&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306163623a4535eda&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2617659171","title":"诺诚健华03月06日获主力加仓163.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2617659171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617659171?lang=zh_cn&edition=full","pubTime":"2026-03-06 16:15","pubTimestamp":1772784934,"startTime":"0","endTime":"0","summary":"03月06日, 诺诚健华股价涨5.44%，报收11.83元，成交金额7411.0万元，换手率0.42%，振幅5.88%，量比0.99。诺诚健华今日主力资金净流入163.0万元，上一交易日主力净流入420.1万元。该股近5个交易日下跌2.81%，主力资金累计净流入179.3万元；近20日主力资金累计净流入1935.1万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306161743a6aa2b6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260306161743a6aa2b6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"1147441099","title":"诺诚健华（09969）2026年2月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1147441099","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147441099?lang=zh_cn&edition=full","pubTime":"2026-03-04 16:51","pubTimestamp":1772614305,"startTime":"0","endTime":"0","summary":"诺诚健华于2026年3月4日披露截至2026年2月28日的股份变动月报表。报告显示，公司法定股本与已发行股份在该月均无新增发行或回购注销活动，整体股本结构保持不变。诺诚健华注册股本维持在25,000,000,000股普通股，面值每股0.000002美元，注册股本总额仍为50,000美元。同时，公司确认截至2026年2月末仍符合香港联交所对公众持股比例的要求。公告由诺诚健华主席兼执行董事崔霽松博士签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09969"],"gpt_icon":0},{"id":"2616350045","title":"中国Biotech，何时能盈利？","url":"https://stock-news.laohu8.com/highlight/detail?id=2616350045","media":"药通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616350045?lang=zh_cn&edition=full","pubTime":"2026-03-04 15:31","pubTimestamp":1772609513,"startTime":"0","endTime":"0","summary":"不止荣昌生物，经过市场与时间的双重锤炼，一批Biotech已走出阵痛期，亏损成为过去式。和铂医药是国内Biotech BD交易的典范，无论是传统license out还是NewCo，亦或是技术平台合作，和铂医药都已是信手拈来。中国Biotech何时能盈利？因此投资人也需要给予Biotech们一些耐心和信心。众多Biotech谁能在时代的浪潮中脱颖而出，让我们拭目以待。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603041608299542f0aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603041608299542f0aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","06978","LU2328871848.SGD","BK1161","BK1583","09995","LU1969619763.USD","09969"],"gpt_icon":0},{"id":"2617528795","title":"公司问答丨诺诚健华：公司已就奥布替尼(orelabrutinib)与Zeans达成对外授权合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2617528795","media":"格隆汇","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617528795?lang=zh_cn&edition=full","pubTime":"2026-03-04 13:46","pubTimestamp":1772603200,"startTime":"0","endTime":"0","summary":"格隆汇3月4日｜有投资者在互动平台向诺诚健华提问：公司BD给Zeans公司的奥布，Zeans是否已经开始进行临床试验？目前项目进展怎样？是否会对里程碑付款产生影响？ 诺诚健华回复称，公司已就奥布替尼(orelabrutinib)与Zeans达成对外授权合作。根据协议约定，合作方将负责相关区域内的临床开发及后续商业化推进。公司持续与合作方保持密切沟通，项目正按既定开发计划稳步推进。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304134719a6a0ae61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260304134719a6a0ae61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09969"],"gpt_icon":0},{"id":"2617528135","title":"自身免疫新玩家：Prolium携康诺亚/诺诚健华的TCE登场，获得5000万美元A轮融资","url":"https://stock-news.laohu8.com/highlight/detail?id=2617528135","media":"Minhua笔记","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617528135?lang=zh_cn&edition=full","pubTime":"2026-03-04 13:31","pubTimestamp":1772602319,"startTime":"0","endTime":"0","summary":"一家全新的生物技术公司 Prolium Bioscience 正式亮相，并一出手就拿下 5,000 万美元 A 轮融资。该公司的唯一资产 PR203，来自康诺亚和诺诚健华的授权。RTW 领投 5,000 万美元，只押一个资产Prolium 于3月3日宣布完成 5,000 万美元 A 轮融资，由知名生命科学投资机构 RTW Investments 独家支持。但 Prolium 的野心不在肿瘤，而在自身免疫尽管已有肿瘤数据打底，Prolium 并未选择在肿瘤领域深挖，而是优先探索自身免疫适应症。Prolium CEO Scott Requadt 表示：“CD20 是 B 细胞驱动型自身免疫疾病中验证最充分的靶点。”","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030415133697a7f96b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030415133697a7f96b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1574","BK1161","BK1587","02162","BK1583"],"gpt_icon":0},{"id":"2616370344","title":"诺诚健华：首个自主研发的B7H3靶向ADC候选药正在入组患者","url":"https://stock-news.laohu8.com/highlight/detail?id=2616370344","media":"每日经济新闻","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616370344?lang=zh_cn&edition=full","pubTime":"2026-03-03 19:30","pubTimestamp":1772537441,"startTime":"0","endTime":"0","summary":"每经AI快讯，诺诚健华（688428.SH）3月3日在投资者互动平台表示，根据公司业绩预告，公司预计2025年度首次实现扭亏为盈，预计2025年实现营业总收入人民币23.65亿元左右，与上年同期相比增长134%左右，归属于母公司所有者的净利润为6.33亿元左右。公司对于未来包括奥布替尼在内的药品销售、管线进展及商业化合作充满信心。更重要的是，公司的增长逻辑并非依赖单一产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603033660525335.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603033660525335.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ADC","09969","BK1574","BK0239","688428","BK4080","BK1161","BK4231"],"gpt_icon":0},{"id":"2616867317","title":"3月3日诺诚健华跌5.51%，富国精准医疗混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2616867317","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616867317?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:38","pubTimestamp":1772527102,"startTime":"0","endTime":"0","summary":"证券之星消息，3月3日诺诚健华跌5.51%，收盘报21.43元，换手率3.25%，成交量8.73万手，成交额1.91亿元。重仓诺诚健华的前十大公募基金请见下表：该股最近90天内共有1家机构给出评级，增持评级1家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共13家，其中持有数量最多的公募基金为富国基金的富国精准医疗混合A。富国精准医疗混合A目前规模为28.77亿元，最新净值2.8503，较上一交易日下跌2.12%，近一年上涨19.32%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030300029072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09969","BK1574","BK1161","BK0239","688428"],"gpt_icon":0},{"id":"2616343449","title":"每日卖空追踪 | 诺诚健华 03月03日卖空量成交33.8万股，卖空比例为5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616343449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616343449?lang=zh_cn&edition=full","pubTime":"2026-03-03 16:30","pubTimestamp":1772526645,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间03月03日，跌2.95%，卖空量成交33.8万股，较上一交易日减少70.81%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163636a445cf4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303163636a445cf4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1161","09969"],"gpt_icon":0},{"id":"2614837581","title":"每日卖空追踪 | 诺诚健华 02月27日卖空量成交33.9万股，卖空比例为6.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614837581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614837581?lang=zh_cn&edition=full","pubTime":"2026-02-27 16:30","pubTimestamp":1772181044,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间02月27日，涨4.04%，卖空量成交33.9万股，较上一交易日减少72.35%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163624a4367ae4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260227163624a4367ae4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","09969"],"gpt_icon":0},{"id":"2614840998","title":"港股异动 | 诺诚健华(09969)尾盘涨超4% BCL2抑制剂联合奥布替尼3期临床完成患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2614840998","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614840998?lang=zh_cn&edition=full","pubTime":"2026-02-27 15:36","pubTimestamp":1772177779,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，诺诚健华尾盘涨超4%，截至发稿，涨3.96%，报12.08港元，成交额4471.55万港元。消息面上，诺诚健华宣布，公司自主研发的新型BCL2抑制剂mesutoclax联合BTK抑制剂奥布替尼一线治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤的注册性3期临床试验已经完成患者入组。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1408112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","VT","BK1574","BK0239","BK4588","688428","BK4585","09969","VXUS"],"gpt_icon":0},{"id":"2614062136","title":"诺诚健华新型BCL2抑制剂Mesutoclax联合奥布替尼一线治疗CLL/SLL的注册性III期临床试验完成患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2614062136","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614062136?lang=zh_cn&edition=full","pubTime":"2026-02-26 10:40","pubTimestamp":1772073636,"startTime":"0","endTime":"0","summary":"人民财讯2月26日电，诺诚健华2月26日宣布，公司自主研发的新型BCL2抑制剂mesutoclax（ICP-248）联合BTK抑制剂奥布替尼一线治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤（CLL/SLL）的注册性III期临床试验已经完成患者入组。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202602263655089844.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0239","BK4134","09969","III","BK1161","BK1574","688428"],"gpt_icon":0},{"id":"2614196057","title":"每日卖空追踪 | 诺诚健华 02月25日卖空量成交6.8万股，卖空比例为2.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614196057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614196057?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:30","pubTimestamp":1772008248,"startTime":"0","endTime":"0","summary":"诺诚健华北京时间02月25日，跌0.57%，卖空量成交6.8万股，较上一交易日减少87.75%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163642a71d5d6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225163642a71d5d6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0},{"id":"2614115057","title":"诺诚健华02月25日遭主力抛售36.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614115057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614115057?lang=zh_cn&edition=full","pubTime":"2026-02-25 16:15","pubTimestamp":1772007327,"startTime":"0","endTime":"0","summary":"02月25日, 诺诚健华股价跌0.57%，报收12.22元，成交金额2961.3万元，换手率0.16%，振幅1.71%，量比1.01。诺诚健华今日主力资金净流出36.3万元，上一交易日主力净流出402.9万元。该股近5个交易日下跌3.79%，主力资金累计净流出700.0万元；近20日主力资金累计净流出594.5万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225161652a4c661be&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260225161652a4c661be&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","09969","BK1574"],"gpt_icon":0},{"id":"2614747108","title":"节后A股首个交易日 年轻人的“药理财”表现如何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2614747108","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614747108?lang=zh_cn&edition=full","pubTime":"2026-02-24 20:38","pubTimestamp":1771936713,"startTime":"0","endTime":"0","summary":"2月24日，A股节后首个交易日，医药商业板块和医疗器械板块领涨，分别上涨1.28%和0.66%，化学制药上涨0.50%，拉长时间线看，创新药、CXO、高端医疗器械等板块正加速复苏。这一表现，也将创下公司上市以来归母净利润的历史新高。昔日“疫苗之王”智飞生物，自上市以来首次年报亏损。目前，智飞生物的代理产品收入占比高达90%，其代理的默沙东HPV疫苗业务缩水，是其业绩下滑的关键因素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224211742a71a1893&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224211742a71a1893&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320764599.SGD","02315","01877","02359","09969","03347","BK1576","LU2045819591.USD","BK1141","LU0052750758.USD","LU2125910500.SGD","09995","BK1574","LU0708995583.HKD","LU2242644610.SGD","06127","06978","BK1161","LU1046422090.SGD","BK1583"],"gpt_icon":0},{"id":"2614566727","title":"诺诚健华02月24日主力净流出402.9万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2614566727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614566727?lang=zh_cn&edition=full","pubTime":"2026-02-24 16:15","pubTimestamp":1771920917,"startTime":"0","endTime":"0","summary":"02月24日, 诺诚健华股价跌3.38%，报收12.29元，成交金额6486.5万元，换手率0.36%，振幅5.58%，量比2.11。诺诚健华今日主力资金净流出402.9万元，上一交易日主力净流出0万元。该股近5个交易日下跌2.22%，主力资金累计净流出84.3万元；近20日主力资金累计净流出2257.9万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161601a4c2212e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260224161601a4c2212e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09969","BK1161","BK1574"],"gpt_icon":0}],"profile":{"websiteUrl":"https://cn.innocarepharma.com","stockEarnings":[{"period":"1week","weight":0.0894},{"period":"1month","weight":-0.0514},{"period":"3month","weight":-0.1018},{"period":"6month","weight":-0.2759},{"period":"1year","weight":0.3097},{"period":"ytd","weight":-0.0098}],"compareEarnings":[{"period":"1week","weight":0.0074},{"period":"1month","weight":-0.0226},{"period":"3month","weight":0.0164},{"period":"6month","weight":-0.0048},{"period":"1year","weight":0.0915},{"period":"ytd","weight":0.0129}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"诺诚健华医药有限公司是一家主要从事生物医药研发、生产和商业化的中国公司。该公司专注于肿瘤和自身免疫性疾病等存在未满足临床需求的领域。该公司的主要产品管线包括奥布替尼、Tafasitamab、ICP-490、ICP-B02、ICP-248、ICP-B05、ICP-332、ICP-488、ICP-192、ICP-723、ICP-033和ICP-189等。其产品主要用于治疗血液瘤、实体瘤和自身免疫疾病。该公司还在开发用于治疗由T细胞功能异常所导致的自身免疫性疾病的产品。该公司在国内和国外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.166667,"avgChangeRate":-0.103999},{"month":2,"riseRate":0.666667,"avgChangeRate":0.128923},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.029218},{"month":4,"riseRate":0.666667,"avgChangeRate":0.116223},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.042592},{"month":6,"riseRate":0.833333,"avgChangeRate":0.12939},{"month":7,"riseRate":0.5,"avgChangeRate":0.039258},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.082108},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.024907},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.033299},{"month":11,"riseRate":0.833333,"avgChangeRate":0.100833},{"month":12,"riseRate":0.5,"avgChangeRate":-0.012645}],"exchange":"SEHK","name":"诺诚健华","nameEN":"INNOCARE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺诚健华(09969)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺诚健华,09969,诺诚健华股票,诺诚健华股票老虎,诺诚健华股票老虎国际,诺诚健华行情,诺诚健华股票行情,诺诚健华股价,诺诚健华股市,诺诚健华股票价格,诺诚健华股票交易,诺诚健华股票购买,诺诚健华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺诚健华(09969)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺诚健华(09969)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}